stavudine has been researched along with Body Weight in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 12 (57.14) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atté, EF; Rasschaert, F; Reid, T; van Griensven, J; Zachariah, R | 1 |
| Iseniyi, JO; Odeigah, L; Olatunji, PO; Olawumi, HO; Salami, AK | 1 |
| Chaisson, RE; Charalambous, S; Churchyard, GJ; Fielding, KL; Grant, AD; Hoffmann, CJ; Innes, C | 1 |
| Corbett, AH; Hosseinipour, MC; Kanyama, C; Kashuba, AD; Kazembe, P; Mkupani, P; Mwansambo, C; Nyirenda, J; Rezk, NL; Sichali, D; Tien, H; Weigel, R | 1 |
| Burger, DM; Chintu, C; Cook, A; Ferrier, A; Fillekes, Q; Gibb, DM; Kabamba, D; Kankasa, C; Mulenga, V; Thomason, MJ; Walker, AS | 1 |
| Bagenda, DS; Barlow-Mosha, LN; Butler, LM; Fowler, MG; Mubiru, MC; Mudiope, PK; Musoke, PM | 1 |
| Bastin, J; Begriche, K; Fromenty, B; Guimont, MC; Igoudjil, A; Laigneau, JP; Lettéron, P; Maisonneuve, C; Pessayre, D | 1 |
| Bressolle, F; Compagnucci, A; Faye, A; Giaquinto, C; Gibbs, D; Gomeni, R; Jacqz-Aigrain, E; Payen, S | 1 |
| Bowonwatanuwong, C; Desakorn, V; Krudsood, S; Pitisuttithum, P; Tin, EE; Wilairatana, P | 1 |
| D'Cruz, OJ; Erbeck, D; Uckun, FM | 1 |
| Olatunji, PO; Olawumi, HO | 1 |
| Cecelia, AJ; Kumarasamy, N; Mayer, K; Saghayam, S; Solomon, S; Wanke, C | 1 |
| Bogner, J; Claas, GJ; Goebel, FD; Jülg, B | 1 |
| Kamerman, PR; Mitchell, D; Weber, J | 1 |
| Burger, DM; Chintu, C; Ewings, FM; Gibb, DM; Kabamba, D; Kankasa, C; L'homme, RF; Mulenga, V; Thomason, MJ; Walker, AS | 1 |
| Church, JA; Dunkle, LM; Federici, ME; Goldsmith, JC; Harris, AT; Kaul, S; Kline, MW; Loewen, DF; Schultze, ME; Woods, L | 1 |
| Skowron, G | 1 |
| Adler, M; Anderson, RE; Cross, A; Dunkle, LM; Kriesel, D; Martin, RR; Smaldone, L; Wirtz, C | 1 |
| Anderson, RE; Cross, A; Dunkle, LM; Hassett, J; Murray, HW; Sacks, HS; Sledz, S; Squires, KE; Weiss, W | 1 |
| Briqnac, H; Miller, LK; Olson, PE; Wallace, MR | 1 |
| Elmadfa, I; Jilma, B; Parschalk, B; Pernerstorfer-Schoen, H; Schindl, A; Schindler, K; Thoeny-Lampert, S; Tschachler, E; Wunderer, K | 1 |
1 review(s) available for stavudine and Body Weight
| Article | Year |
|---|---|
Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine | 1995 |
13 trial(s) available for stavudine and Body Weight
| Article | Year |
|---|---|
Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Female; Hospitals, Teaching; Hospitals, University; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Stavudine; Treatment Outcome | 2008 |
HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa.
Topics: Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Female; HIV Infections; HIV-1; Humans; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viral Load | 2009 |
Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.
Topics: Adolescent; Anti-HIV Agents; Body Weight; Child; Child, Preschool; Cross-Over Studies; Dosage Forms; Drug Administration Schedule; Drugs, Generic; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Malawi; Male; Nevirapine; Prospective Studies; Stavudine | 2010 |
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Infant; Infant, Newborn; Lamivudine; Male; Nevirapine; Stavudine; Viral Load; Zambia | 2012 |
Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
Topics: Aging; Bayes Theorem; Body Weight; Chromatography, High Pressure Liquid; Didanosine; Drug Interactions; Half-Life; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Models, Biological; Nelfinavir; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization; Stavudine | 2005 |
The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.
Topics: Adolescent; Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Stavudine | 2005 |
The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.
Topics: Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Predictive Value of Tests; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Serum Albumin; Severity of Illness Index; Stavudine; Treatment Outcome | 2006 |
Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Didanosine; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Hemoglobins; HIV Infections; Humans; Lactic Acid; Male; Middle Aged; Organophosphonates; Phosphates; Skinfold Thickness; Stavudine; Tenofovir; Treatment Outcome; Triglycerides; Uric Acid; Viral Load | 2007 |
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
Topics: Adolescent; Antiretroviral Therapy, Highly Active; Area Under Curve; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Female; HIV Infections; Humans; Infant; Infant, Newborn; Lamivudine; Male; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zambia | 2008 |
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Female; Growth; HIV Core Protein p24; HIV Infections; Humans; Infant; Male; Stavudine; Survival Rate; Zidovudine | 1995 |
Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine | 1995 |
Design and implementation of the stavudine parallel-track program.
Topics: Adult; Body Weight; Double-Blind Method; Female; HIV Infections; Humans; Male; Peripheral Nervous System Diseases; Regression Analysis; Stavudine; Survival Rate | 1995 |
Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Female; HIV Core Protein p24; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Proportional Hazards Models; Stavudine; Survival Analysis | 1995 |
8 other study(ies) available for stavudine and Body Weight
| Article | Year |
|---|---|
Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir.
Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Organophosphonates; Rwanda; Stavudine; Tenofovir; Treatment Outcome; Weight Loss; Zidovudine | 2009 |
The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drugs, Generic; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Kaplan-Meier Estimate; Lamivudine; Male; Medication Adherence; Nevirapine; Stavudine; Time Factors; Treatment Outcome; Viral Load | 2012 |
Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting.
Topics: Aminoisobutyric Acids; Animals; Anti-HIV Agents; Body Weight; Homeostasis; Lipid Metabolism; Lipodystrophy; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Reverse Transcriptase Inhibitors; Stavudine; Thinness; Zidovudine | 2004 |
Developmental safety profile of the anti-HIV agent stampidine in rabbits.
Topics: Animals; Anti-HIV Agents; Body Weight; Capsules; Chemistry, Pharmaceutical; Dideoxynucleotides; Eating; Excipients; Female; Fetal Development; Gelatin; Pregnancy; Rabbits; Reproduction; Skeleton; Stavudine; Teratogens; Thymidine Monophosphate | 2006 |
Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Weight; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; India; Lamivudine; Male; Nevirapine; Stavudine; Zidovudine | 2007 |
Oral administration of stavudine induces hyperalgesia without affecting activity in rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Antimetabolites; Behavior, Animal; Body Mass Index; Body Weight; Eating; Female; Hyperalgesia; Motor Activity; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reaction Time; Running; Stavudine | 2007 |
Clinical experience with stavudine as salvage therapy in patients with advanced HIV disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antiviral Agents; Body Weight; HIV Infections; Humans; Middle Aged; Salvage Therapy; Stavudine | 1996 |
Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Basal Metabolism; Body Composition; Body Weight; Case-Control Studies; Cohort Studies; Didanosine; Energy Metabolism; Female; HIV Infections; HIV Protease Inhibitors; Humans; Longitudinal Studies; Male; Middle Aged; Nelfinavir; Prospective Studies; Stavudine; Viremia | 1999 |